Schizoaffective Disorders Completed Phase 1 Trials for Aripiprazole (DB01238)

Also known as: Schizoaffective disorder / Schizophrenia schizoaffective / Schizoaffective psychosis / Schizo-affective type schizophrenia

IndicationStatusPhase
DBCOND0033299 (Schizoaffective Disorders)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02636842A Study of Aripiprazole Lauroxil in Subjects With Schizophrenia or Schizoaffective DisorderTreatment